Sectors
TTRX
Turn Therapeutics Inc.
9.60
1 x 7.65
1 x 7.37
bid
ask
-
0.24
2.44%
1 @ 04:10 PM
9.60 +0.00 (0.00%)
| Ytd | 143.65% | |
| 1y | 37.14% |
9.53
day range
10.25
2.57
52 week range
26.50
| Open | 9.83 | Prev Close | 9.84 | Low | 9.53 | High | 10.25 | Mkt Cap | 291.53M |
| Vol | 31.58K | Avg Vol | 80.68K | EPS | -0.28 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 8.80 | 200-d Avg | 5.17 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.63M | ||
| Research and Development Expense | 475.06K | ||
| Selling, General and Administrative Expense | 1.15M | ||
| Operating Income | -1.63M | ||
| Interest Expense | 241.36K | ||
| Net Income | -5.85M | ||
| Net Income Common Stock | -5.85M | ||
| Net Income Common Stock (USD) | -5.85M | ||
| Consolidated Income | -5.85M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -5.61M | ||
| Earning Before Interest & Taxes (USD) | -5.61M | ||
| Weighted Average Shares | 29.79M | ||
| Weighted Average Shares Diluted | 29.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.29M | ||
| Cash and Equivalents (USD) | 10.29M | ||
| Current Assets | 10.43M | ||
| Property, Plant & Equipment Net | 56.28K | ||
| Total Assets | 16.96M | ||
| Debt Current | 49.33K | ||
| Total Debt | 6.12M | ||
| Current Liabilities | 8.76M | ||
| Debt Non-Current | 6.07M | ||
| Total Liabilities | 16.27M | ||
| Accumulated Retained Earnings (Deficit) | -29.21M | ||
| Shareholders Equity | 686.89K | ||
| Shareholders Equity (USD) | 686.89K | ||
| Assets Non-Current | 6.53M | ||
| Total Debt (USD) | 6.12M | ||
| Deferred Revenue | 1.44M | ||
| Goodwill and Intangible Assets | 911.22K | ||
| Liabilities Non-Current | 7.51M | ||
| Trade and Non-Trade Payables | 2.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 14.53K | ||
| Net Cash Flow from Financing | 1.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -929.16K | ||
| Issuance (Repayment) of Debt Securities | 1.00 | ||
| Net Cash Flow from Investing | -5.80K | ||
| Net Cash Flow from Operations | -923.36K | ||
| Share Based Compensation | 419.23K | ||